Literature DB >> 30814250

Specificity from nonspecific interaction: regulation of tumor necrosis factor-α activity by DNA.

Helena Andrade1, Weilin Lin1, Yixin Zhang2.   

Abstract

As anionic biopolymers, oligonucleotides can have biological functions independent from their roles as the medium for the storage and flow of genetic information. In this paper, we investigated the interaction between DNA and the pro-inflammatory cytokine tumor necrosis factor-α (TNFα). Although various forms of DNA bind to TNFα with low μm dissociation constants, the interaction stabilizes the trimeric form of TNFα and enhances its cytotoxic effect. Based on this mechanism, a photoswitchable TNFα (TNFα-2-nitroveratryloxycarbonyl) has been designed whose sensitivity to DNA-mediated up-regulation of TNFα activity can be tuned by light irradiation. The mechanism described in this study represents a general model to understand the involvement of nonspecific interactions among biomolecules in regulating their biological functions. Because the interaction is not DNA sequence-specific, the resulting effect should be considered for oligonucleotide-based therapeutics in general.
© 2019 Andrade et al.

Entities:  

Keywords:  DNA–protein interaction; activity regulation; allosteric regulation; biolayer interferometry; circular dichroism (CD); homoquenching; nonspecific interaction; photo-switchable protein; protein–nucleic acid interaction; tumor necrosis factor (TNF)

Mesh:

Substances:

Year:  2019        PMID: 30814250      PMCID: PMC6484132          DOI: 10.1074/jbc.RA119.007586

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding.

Authors:  M J Eck; S R Sprang
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

2.  Circulating nucleic acids in blood of healthy male and female donors.

Authors:  Svetlana N Tamkovich; Olga E Bryzgunova; Elena Yu Rykova; Valentina I Permyakova; Valentin V Vlassov; Pavel P Laktionov
Journal:  Clin Chem       Date:  2005-07       Impact factor: 8.327

3.  Gene-silencing technology gets first drug approval after 20-year wait.

Authors:  Heidi Ledford
Journal:  Nature       Date:  2018-08       Impact factor: 49.962

4.  Small-molecule inhibition of TNF-alpha.

Authors:  Molly M He; Annemarie Stroustrup Smith; Johan D Oslob; William M Flanagan; Andrew C Braisted; Adrian Whitty; Mark T Cancilla; Jun Wang; Alexey A Lugovskoy; Josh C Yoburn; Amy D Fung; Graham Farrington; John K Eldredge; Eric S Day; Leslie A Cruz; Teresa G Cachero; Stephan K Miller; Jessica E Friedman; Ingrid C Choong; Brian C Cunningham
Journal:  Science       Date:  2005-11-11       Impact factor: 47.728

5.  I-motif DNA structures are formed in the nuclei of human cells.

Authors:  Mahdi Zeraati; David B Langley; Peter Schofield; Aaron L Moye; Romain Rouet; William E Hughes; Tracy M Bryan; Marcel E Dinger; Daniel Christ
Journal:  Nat Chem       Date:  2018-04-23       Impact factor: 24.427

6.  How the thymus designs antigen-specific and self-tolerant T cell receptor sequences.

Authors:  Andrej Kosmrlj; Abhishek K Jha; Eric S Huseby; Mehran Kardar; Arup K Chakraborty
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-22       Impact factor: 11.205

7.  Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity.

Authors:  K Haugbro; J C Nossent; T Winkler; Y Figenschau; O P Rekvig
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

Review 8.  Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see).

Authors:  Ludger Klein; Bruno Kyewski; Paul M Allen; Kristin A Hogquist
Journal:  Nat Rev Immunol       Date:  2014-05-16       Impact factor: 53.106

9.  Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease.

Authors:  A Szpechcinski; J Chorostowska-Wynimko; R Struniawski; W Kupis; P Rudzinski; R Langfort; E Puscinska; P Bielen; P Sliwinski; T Orlowski
Journal:  Br J Cancer       Date:  2015-06-30       Impact factor: 7.640

10.  Post-ExSELEX stabilization of an unnatural-base DNA aptamer targeting VEGF165 toward pharmaceutical applications.

Authors:  Michiko Kimoto; Mana Nakamura; Ichiro Hirao
Journal:  Nucleic Acids Res       Date:  2016-07-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.